Late Breaking Abstract - Implication of the KATP Sur2b/Kir6.1 in the physiopathology of pulmonary arterial hypertension

H. Le Ribeuz (Le plessis robinson, France), M. Dutheil (Le plessis robinson, France), V. Capuano (Le plessis robinson, France), O. Mercier (Le plessis robinson, France), M. Humbert (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France), F. Antigny (Le plessis robinson, France)

Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Session: Pathogenesis and pathophysiology of pulmonary hypertension
Session type: E-poster
Number: 600

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Le Ribeuz (Le plessis robinson, France), M. Dutheil (Le plessis robinson, France), V. Capuano (Le plessis robinson, France), O. Mercier (Le plessis robinson, France), M. Humbert (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France), F. Antigny (Le plessis robinson, France). Late Breaking Abstract - Implication of the KATP Sur2b/Kir6.1 in the physiopathology of pulmonary arterial hypertension. 600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


Late Breaking Abstract - Morphine for dyspnea in advanced pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
Source: Eur Respir Rev 2013; 22: 543-551
Year: 2013



Pathophysiology of pulmonary hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012



Pathophysiology of pulmonary hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Pathophysiology of pulmonary hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014


Pathophysiology of pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Role of NMDA receptors in vascular remodelling associated to pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Nuclear IL-33 arguments ST2 receptor expression in pulmonary arterial endothelial cells: Implication in the pathogenesis and progression of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020


Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018

LSC 2014 abstract - Inhibition of the HIF/leptin/ObR axis prevents experimental pulmonary hypertension and attenuates treg impairment
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014

Late Breaking Abstract - Effects of preventive exercise in monocrotaline rat model with pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019


Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease.
Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities
Year: 2019

Olfactory receptors in pulmonary arterial hypertension: A novel pathway of vascular remodeling?
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Late Breaking Abstract - Pulmonary hypertension modifies cardiac genes myh7 and col1a1 nonreversible by training
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017

Limited and heterogeneous arterial narrowing in idiopathic pulmonary hypertension: Rethinking resistance
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021



Pathophysiology of the pulmonary circulation
Source: International Congress 2016 – PG17 Pulmonary haemodynamics during exercise
Year: 2016